基于专利计量的中美医药产业创新网络对比分析  

Development of innovation network in China and USA pharmaceutical industries based on patent bibliometric analysis

作　　者：阿丽塔[1,2] 刘晓婷[2] 张玢[2] 张燕舞[2] 武志昂[1] 

机构地区：[1]沈阳药科大学,沈阳110016 [2]中国医学科学院医学信息研究所,北京100005

出　　处：《中国新药杂志》2014年第11期1237-1247,共11页Chinese Journal of New Drugs

基　　金：中央级公益性科研院所基本科研业务(12R0120)

摘　　要：目的:利用文献计量学的方法研究中美两国医药产业创新网络的演变。方法:在汤森路透集团Thomson Innovation(TI)专利数据库中检索中美两国1975,1980,1985,1990,1995,2000,2005,2010年的A61K*专利,利用文献计量软件Thomson Data Analyzer和社会网络分析工具Ucinet,以网络密度、网络中心势为指标,对中美两国的大学/科研机构创新网络、企业创新网络、大学/科研机构-企业创新网络进行测算,在此基础上从组织层面揭示中国医药产业创新网络的特点和演变规律。结果和结论:中国医药产业创新网络处于起步发展阶段,美国医药产业经历了多年的发展已经从独立发展阶段、本地化发展阶段过渡到全球化发展阶段。我国医药产业创新网络的完善需要多方面共同努力。Objective： To introduce the bibliometric method into the field of pharmaceutical innovation. Methods： The patents applied in China and USA were selected by searching Thomson Innovation （TI） patent data- base using International Patent Classification ＂A61K ＊ ＂. The applied years were 1975, 1980, 1985, 1990, 1995, 2000, 2005 and 2010. With the help of the bibliometric software package Thomson Data Analyze and social network software package Ucinet, we analyzed different types of innovation network in China and USA, such as university/institute innovation network, enterprise innovation network, university/institute-enterprise innovation network. Results and Conclusion： In the past forty years, China pharmaceutical industry innovation network just began to develop. The pharmaceutical industry innovation network in USA has been prosperous for a long time, and has turned into a global stage. Thus, in order to accelerate the development of Chinese pharmaceutical industry, we should broaden the innovation network scale and increase the density.

关 键 词：专利 计量学方法 医药产业 创新网络 

分 类 号：R95[医药卫生—药学]